UPDATED Jun 30, 2022
Stocks with a market cap under US$50M.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
SANNSanthera Pharmaceuticals Holding | CHF0.89 | -11.6% | -66.5% | CHF46.2m | CHF5.50 | PB34.8x | E67.5% | n/a | Pharmaceuticals & Biotech | ||
ADMIAdmicasa Holding | CHF17.50 | 0% | 105.9% | CHF37.0m | n/a | PB7.1x | n/a | 0.7% | Real Estate | ||
STRNSchlatter Industries | CHF28.80 | -0.7% | 13.4% | CHF31.8m | n/a | PE6.6x | n/a | n/a | Capital Goods | ||
ASWNAsmallworld | CHF2.45 | -3.9% | -21.0% | CHF28.7m | CHF7.20 | PE18.2x | E22.6% | n/a | Media | ||
NWRNNewron Pharmaceuticals | CHF1.53 | -0.6% | -39.0% | CHF27.3m | CHF9.25 | PS4.7x | E54.6% | n/a | Pharmaceuticals & Biotech | ||
SEANSwiss Estates | CHF3.00 | 0% | -38.5% | CHF11.6m | n/a | PE1.4x | n/a | n/a | Real Estate | ||
ADXNAddex Therapeutics | CHF0.18 | -14.3% | -88.8% | CHF6.8m | n/a | PS2.8x | E29.3% | n/a | Pharmaceuticals & Biotech | ||
EEIIEEII | CHF2.00 | 0% | -43.8% | CHF3.1m | n/a | PE1.3x | n/a | 0% | Diversified Financials | ||
AHANACRON HELVETIA I Immobilien | CHF0.38 | 0% | -94.8% | CHF364.5k | n/a | n/a | n/a | 1,102.6% | Real Estate |